🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseGLP-1 hepatoprotection — looking for input Page 3

GLP-1 hepatoprotection — looking for input

emma_london Sat, Jan 3, 2026 at 5:22 PM 32 replies 1,569 viewsPage 3 of 7
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Jan 4, 2026 at 11:00 AM#11
chris_chi24 said:
Liver imaging follow-up for liver and MASH: FibroScan at baseline showed CAP score 316 dB/m (moderate steatosis) and stiffness 9.8 kPa (possible…

Bookmarking. The distinction being drawn above is the one nobody else makes. I will report back once I have actually tried it.

3 1andrew_nyc, Dr.EndoEP, GraceAZ_72
Reply Quote Save Share Report
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Jan 4, 2026 at 1:13 PM#12

Adding the clinical framing, because it changes how the question reads. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Happy to go further on any of that.

4 2Dr.GutHealth, amsterdam_pete, LondonLisa and 1 other
Reply Quote Save Share Report
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
Jan 4, 2026 at 3:26 PM#13
NurseAsh_DET said:
Liver enzyme update related to liver and MASH: I had mildly elevated ALT/AST at baseline (likely NAFLD).

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.

Last edited: Jan 4, 2026 at 8:26 PM
5 3jennifer_SEA, tyler_CSCS, VanRx_Mike and 2 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Jan 4, 2026 at 5:39 PM#14

One concrete data point for the thread. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.

6 4sophie_paris, mel_PDX, Dr.AddMedPHL and 3 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jan 4, 2026 at 7:52 PM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Tagging this one for the weekly digest.

7 5PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 4 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register